Drugs / Autologous adipose-derived mesenchymal stem/stromal cells
Autologous adipose-derived mesenchymal stem/stromal cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03876197 | Aug 2020 → Dec 2022 | radiation-induced disorder | Rigshospitalet, Denmark | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous adipose-derived mesenchymal stem/stromal cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03876197 ↗ |
| Modality | Cell therapy | “Autologous adipose-derived mesenchymal stem/stromal cells” NCT03876197 ↗ |
| Route | Other | “Autologous adipose-derived mesenchymal stem cells transplanted intraglandular in patients with radiation-induced hyposalivation and xerostomia” NCT03876197 ↗ |